Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 260 participants.

Also called NCT07585968

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 260 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07585968
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07585968. Allocation not applicable; no masking; primary purpose treatment. Start 2026-08-17 (actual); primary completion 2028-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)
Condition
Ventricular Tachycardia
Intervention (Device)
Sphere-9 Catheter with the Affera Mapping and Ablation System
Lead sponsor
Medtronic Cardiac Ablation Solutions (class: industry)

Record details

Record id
cardio:ct-nct07585968
Content hash
269a9811404eb022ed9cdee35cfed99d150c1ae0f6e905796c38769aa9adbe0a